Description
A metabolite of doxorubicin; inhibits mitochondrial succinoxidase from bovine heart; reduces the mitochondrial inner membrane potential in rat heart and liver mitochondria; increases pentose phosphate pathway flux by 45% and reduces activity of GPx and SOD by 17 and 60%, respectively, in human erythrocytes at 40 μM; induces cytotoxicity in patient-derived ovarian cancer colonies
Formal name: (8S,10S)-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
Synonyms: Adriamycin aglycone|Adriamycinone|aglycone-DOX|Doxorubicin aglycone|Epirubicin aglycone
Molecular weight: 414.4
CAS: 24385-10-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ox Stress Reagents|Antioxidants||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Cancer|Cell Death||Research Area|Cell Biology|Mitochondrial Biology